バイオシミラー成長ホルモンの世界市場レポート 2024

バイオシミラー成長ホルモンの市場規模は、今後数年間で大幅に成長すると予想されます。 2028年には9.8%の年間平均成長率（CAGR）で11億9,000万米ドルに成長すると予想されています。予測期間における予想される成長は、いくつかの重要な要因によってもたらされると予想されます。これらには、小児の成長障害への注目、バイオシミラー治療の適応範囲の拡大、意識の向上による診断の増加、ヘルスケア提供者と患者の間でのバイオシミラーの選択肢の認識などが含まれます。

世界のバイオシミラー成長ホルモン市場は、小児における成長ホルモン欠乏症の発生率の増加により成長を遂げています。この欠乏症は、下垂体または視床下部の損傷によって引き起こされ、乳児約3,800人に1人が罹患しており、脳腫瘍、手術、感染症などのさまざまな要因により、後になって発症する可能性もあります。影響を受ける子どもの数が増加しているため、バイオシミラー成長ホルモンの需要が高まっています。

世界の慢性疾患の蔓延により、バイオシミラー成長ホルモン市場が加速すると予想されます。慢性疾患は治癒可能ではありませんが、管理可能であり、バイオシミラー成長ホルモンは、特に成長障害や慢性腎臓病のある子供に効果的であることが証明されています。国立医学図書館の予測によると、米国では2050年までに50歳以上の慢性疾患を持つ人の数が99.5%と大幅に増加し、2020年の7,152万2,000人から急増し、バイオシミラー成長ホルモンの需要が高まります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のバイオシミラー成長ホルモン市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 静脈内
• 皮下
• 筋肉内
• 経口
• 世界のバイオシミラー成長ホルモン市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 成長ホルモン欠乏症
• ターナー症候群
• 特発性低身長
• プラダー・ウィリ症候群
• その他の用途
• 世界のバイオシミラー成長ホルモン市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院および小売薬局
• オンライン薬局/e薬局
• 専門クリニック

第7章 地域および国の分析

• 世界のバイオシミラー成長ホルモン市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のバイオシミラー成長ホルモン市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオシミラー成長ホルモン市場の競合情勢
• バイオシミラー成長ホルモン市場の企業プロファイル
  • Amega Biotech
  • Biosidus SA
  • Eli Lilly and Company
  • Ferring Pharmaceuticals
  • Genentech Inc

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

Biosimilar growth hormone is a peptide hormone vital for stimulating cellular regeneration, cell division, and overall growth in humans and other organisms. Its significance lies in its role in advancing human development, serving as a targeted mitogen affecting specific cell types.

These hormones are administered through various routes such as intravenous, subcutaneous, intramuscular, and oral methods. Intravenous administration involves the injection of fluids, medications, or nutrients directly into a patient's vein. Applications for biosimilar growth hormones encompass treating conditions like growth hormone deficiency, Turner syndrome, idiopathic short stature, Prader-Willi syndrome, among others. These treatments are available through diverse distribution channels including hospital and retail pharmacies, online pharmacy platforms, and specialty clinics.

The biosimilar growth hormone market research report is one of a series of new reports from The Business Research Company that provides biosimilar growth hormone market statistics, including biosimilar growth hormone industry global market size, regional shares, competitors with a biosimilar growth hormone market share, detailed biosimilar growth hormone market segments, market trends and opportunities, and any further data you may need to thrive in the biosimilar growth hormone industry. This biosimilar growth hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biosimilar growth hormones market size has grown strongly in recent years. It will grow from $0.76 billion in 2023 to $0.82 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historical period can be attributed to several factors. These include a growing demand for growth hormones, the expiration of patents enabling the development of biosimilar alternatives, the availability of clinical evidence supporting their efficacy, and an increase in clinical trials aimed at exploring their applications and benefits. These factors collectively contributed to the expansion and development of biosimilar growth hormones during this period.

The biosimilar growth hormones market size is expected to see strongly grown in the next few years. It will grow to $1.19 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. Anticipated growth in the forecast period is expected to stem from several key factors. These include the focus on pediatric growth disorders, the widening scope of indications for biosimilar treatments, a rise in diagnoses due to increased awareness, and the recognition of biosimilar options among healthcare providers and patients.

The global biosimilar growth hormone market is experiencing growth due to the increasing incidence of growth hormone deficiency among children. This deficiency, caused by pituitary or hypothalamic damage, affects about 1 in every 3,800 babies and can also occur later due to various factors like brain tumors, surgeries, or infections. The rising number of affected children drives the demand for biosimilar growth hormones.

The prevalence of chronic diseases globally is anticipated to fuel the biosimilar growth hormone market. Chronic conditions, while not curable, are manageable, and biosimilar growth hormones have proven effective, especially for children with growth disorders and chronic kidney disease. As projected by the National Library of Medicine, the US will witness a significant 99.5% rise in individuals aged 50 and above with chronic illnesses by 2050, soaring from 71.522 million in 2020, boosting the demand for biosimilar growth hormones.

The implementation of recombinant DNA technology in the biosimilar growth hormone sector is a burgeoning trend. Notably, Pfizer Inc.'s initiation of a Phase III clinical trial utilizing somatropin, a growth hormone developed via recombinant DNA technology, emphasizes this. The trial assesses the efficacy and safety of somatropin for addressing growth hormone deficiency in children, focusing on a cohort with Prader-Willi Syndrome.

Key players in the biosimilar growth hormone market are introducing innovative products like NGENLA to enhance market profitability. Pfizer Inc.'s recent FDA approval for NGENLA, a once-weekly administered human growth hormone analog, targets pediatric patients aged three and older experiencing growth failure due to inadequate secretion of their own growth hormone. This product, slated for availability in the US from August 2023, aims to address growth hormone deficiencies more conveniently.

In October 2023, the US-based biotechnology company Amgen completed the acquisition of Horizon Therapeutics plc for a substantial $27.8 billion. This strategic move aligns with Amgen's overarching goal of providing innovative and impactful medications to patients dealing with severe illnesses. The acquisition notably includes Horizon's pharmaceutical portfolio, encompassing Tepezza, designed to address thyroid eye disease, Krystexxa, targeting chronic refractory gout, and Uplizna, intended for neuromyelitis optica spectrum disorder.

Major companies operating in the biosimilar growth hormones market include Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Coherus BioSciences Inc., Daiichi Sankyo Company Ltd., Dr. Reddy's Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., GenScript Biotech Corporation, Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Oncobiologics Inc., Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation

North America was the largest region in the biosimilar growth hormone market in 2023. The Middle East is expected to be the fastest-growing region in the biosimilar growth hormones market report during the forecast period. The regions covered in the biosimilar growth hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the biosimilar growth hormones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The biosimilar growth hormone market consists of sales of teriparatide, follitropin alfa, insulin, and somatropin. Values in this market are 'factory gate values,' that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biosimilar Growth Hormones Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biosimilar growth hormones market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biosimilar growth hormones? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biosimilar growth hormones market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular; Oral
• 2) By Application: Growth Hormone Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader Willi Syndrome; Other Applications
• 3) By Distribution Channel: Hospital And Retail Pharmacy; Online Pharmacy/ePharmacy; Specialty Clinics
• Companies Mentioned: Amega Biotech; Biosidus S.A.; Eli Lilly and Company; Ferring Pharmaceuticals; Genetech Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biosimilar Growth Hormones Market Characteristics

3. Biosimilar Growth Hormones Market Trends And Strategies

4. Biosimilar Growth Hormones Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Biosimilar Growth Hormones Market Size and Growth

• 5.1. Global Biosimilar Growth Hormones Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Biosimilar Growth Hormones Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Biosimilar Growth Hormones Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biosimilar Growth Hormones Market Segmentation

• 6.1. Global Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Intravenous
• Subcutaneous
• Intramuscular
• Oral
• 6.2. Global Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Growth Hormone Deficiency
• Turner Syndrome
• Idiopathic Short Stature
• Prader Willi Syndrome
• Other Applications
• 6.3. Global Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital And Retail Pharmacy
• Online Pharmacy/ePharmacy
• Specialty Clinics

7. Biosimilar Growth Hormones Market Regional And Country Analysis

• 7.1. Global Biosimilar Growth Hormones Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Biosimilar Growth Hormones Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biosimilar Growth Hormones Market

• 8.1. Asia-Pacific Biosimilar Growth Hormones Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biosimilar Growth Hormones Market

• 9.1. China Biosimilar Growth Hormones Market Overview
• 9.2. China Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biosimilar Growth Hormones Market

• 10.1. India Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biosimilar Growth Hormones Market

• 11.1. Japan Biosimilar Growth Hormones Market Overview
• 11.2. Japan Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biosimilar Growth Hormones Market

• 12.1. Australia Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biosimilar Growth Hormones Market

• 13.1. Indonesia Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biosimilar Growth Hormones Market

• 14.1. South Korea Biosimilar Growth Hormones Market Overview
• 14.2. South Korea Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biosimilar Growth Hormones Market

• 15.1. Western Europe Biosimilar Growth Hormones Market Overview
• 15.2. Western Europe Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biosimilar Growth Hormones Market

• 16.1. UK Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biosimilar Growth Hormones Market

• 17.1. Germany Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biosimilar Growth Hormones Market

• 18.1. France Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biosimilar Growth Hormones Market

• 19.1. Italy Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biosimilar Growth Hormones Market

• 20.1. Spain Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biosimilar Growth Hormones Market

• 21.1. Eastern Europe Biosimilar Growth Hormones Market Overview
• 21.2. Eastern Europe Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biosimilar Growth Hormones Market

• 22.1. Russia Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biosimilar Growth Hormones Market

• 23.1. North America Biosimilar Growth Hormones Market Overview
• 23.2. North America Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biosimilar Growth Hormones Market

• 24.1. USA Biosimilar Growth Hormones Market Overview
• 24.2. USA Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biosimilar Growth Hormones Market

• 25.1. Canada Biosimilar Growth Hormones Market Overview
• 25.2. Canada Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biosimilar Growth Hormones Market

• 26.1. South America Biosimilar Growth Hormones Market Overview
• 26.2. South America Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biosimilar Growth Hormones Market

• 27.1. Brazil Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biosimilar Growth Hormones Market

• 28.1. Middle East Biosimilar Growth Hormones Market Overview
• 28.2. Middle East Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biosimilar Growth Hormones Market

• 29.1. Africa Biosimilar Growth Hormones Market Overview
• 29.2. Africa Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biosimilar Growth Hormones Market Competitive Landscape And Company Profiles

• 30.1. Biosimilar Growth Hormones Market Competitive Landscape
• 30.2. Biosimilar Growth Hormones Market Company Profiles
  • 30.2.1. Amega Biotech
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Biosidus S.A.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Eli Lilly and Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Ferring Pharmaceuticals
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Genentech Inc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Biosimilar Growth Hormones Market Competitive Benchmarking

32. Global Biosimilar Growth Hormones Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Biosimilar Growth Hormones Market

34. Biosimilar Growth Hormones Market Future Outlook and Potential Analysis

• 34.1 Biosimilar Growth Hormones Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Biosimilar Growth Hormones Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Biosimilar Growth Hormones Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer